Salesforce (CRM)CFO sold ~$2.05M

~$2.05M

Approx. value · 6,221 sh @ $329.88

46K

Holds after · shares reported

Traded

Jan 15, 2025

Filed

Jan 16, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Oct 28, 2024CongressDisclosed purchase of CRM — reported range $15,001 - $50,000
2. Nov 12, 2024CongressDisclosed purchase of CRM — reported range $1,001 - $15,000
3. Nov 13, 2024CongressDisclosed purchase of CRM — reported range $1,001 - $15,000
4. Nov 14, 2024CongressDisclosed purchase of CRM — reported range $1,001 - $15,000
5. Nov 22, 2024InsiderOfficer sold ~$5.02M of CRM shares in the open market
6. Nov 25, 2024Insider · 2 peopleInsiders: 2 sales (~$566K)
7. Nov 26, 2024InsiderOfficer sold ~$187K of CRM shares in the open market
8. Dec 13, 2024CongressDisclosed purchase of CRM — reported range $1,001 - $15,000
9. Dec 18, 2024Insider · 2 peopleInsiders: 20 sales (~$360.0M)
10. Dec 19, 2024InsiderDirector sold ~$94.8M of CRM shares in the open market
11. Dec 20, 2024InsiderDirector sold ~$5.23M of CRM shares in the open market
12. Dec 23, 2024Insider · 6 peopleInsiders: 21 sales (~$65.6M)
13. Dec 24, 2024Insider · 2 peopleInsiders: 2 sales (~$2.7M)
14. Dec 26, 2024InsiderOfficer sold ~$614K of CRM shares in the open market
15. Jan 2, 2025InsiderCFO sold ~$2.11M of CRM shares in the open market
16. Jan 2, 2025CongressDisclosed purchase of CRM — reported range $1,001 - $15,000
17. Jan 13, 2025CongressDisclosed sale of CRM — reported range $1,001 - $15,000
18. Jan 14, 2025CongressDisclosed purchase of CRM — reported range $1,001 - $15,000
19. Jan 15, 2025 · this disclosureInsiderCFO sold ~$2.05M of CRM shares in the open market

What came next

1. Jan 21, 2025CongressDisclosed sale of CRM — reported range $15,001 - $50,000
2. Jan 22, 2025InsiderOfficer sold ~$1.47M of CRM shares in the open market
3. Jan 23, 2025Insider · 6 peopleInsiders: 7 sales (~$1.3M)
4. Jan 29, 2025CongressDisclosed purchase of CRM — reported range $1,001 - $15,000
5. Feb 3, 2025Insider · 2 peopleInsiders: 2 sales (~$2.3M)
6. Feb 18, 2025InsiderCFO sold ~$2.04M of CRM shares in the open market
7. Feb 24, 2025Insider · 3 peopleInsiders: 3 sales (~$1.7M)
8. Feb 25, 2025InsiderOfficer sold ~$224K of CRM shares in the open market
9. Feb 28, 2025InsiderDirector purchased ~$499K of CRM shares in the open market
10. Mar 3, 2025InsiderCFO sold ~$1.87M of CRM shares in the open market
11. Mar 17, 2025InsiderCFO sold ~$1.73M of CRM shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Salesforce

For Salesforce, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports, 99 fund holdings reports (13F) and 3 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CRM page.

Other recent filings by Amy E Weaver, President and CFO

• SEC Form 4 at Salesforce (CRM)Mar 18, 2025
• SEC Form 4 at Salesforce (CRM)Mar 4, 2025
• SEC Form 4 at Salesforce (CRM)Feb 19, 2025
• SEC Form 4 at Salesforce (CRM)Feb 4, 2025
• SEC Form 4 at Salesforce (CRM)Jan 23, 2025

The full history of Amy E Weaver, President and CFO is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Salesforce

• House Clerk periodic transaction reportOct 7, 2026
• USAspending.gov award recordSep 23, 2026
• SEC Form 4Sep 21, 2026
• SEC Form 144Sep 4, 2026
• SEC Form 4Sep 4, 2026
• SEC Form 4Sep 4, 2026

Everything OQRO holds on this company is on its CRM page.